These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24362035)

  • 1. Introduction to thematic minireview series: Development of human therapeutics based on induced pluripotent stem cell (iPSC) technology.
    Rao M; Gottesfeld JM
    J Biol Chem; 2014 Feb; 289(8):4553-4. PubMed ID: 24362035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical studies for induced pluripotent stem cell-based therapeutics.
    Harding J; Mirochnitchenko O
    J Biol Chem; 2014 Feb; 289(8):4585-93. PubMed ID: 24362021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology.
    Easley CA
    Methods Mol Biol; 2019; 1965():19-34. PubMed ID: 31069666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present and future challenges of induced pluripotent stem cells.
    Ohnuki M; Takahashi K
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140367. PubMed ID: 26416678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
    Omole AE; Fakoya AOJ
    PeerJ; 2018; 6():e4370. PubMed ID: 29770269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells.
    Cong X; Zhang SM; Ellis MW; Luo J
    Stem Cells Dev; 2019 Oct; 28(19):1288-1298. PubMed ID: 31359827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent technological updates and clinical applications of induced pluripotent stem cells.
    Diecke S; Jung SM; Lee J; Ju JH
    Korean J Intern Med; 2014 Sep; 29(5):547-57. PubMed ID: 25228828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Induced pluripotent stem cell technology and its application in disease research].
    Cai CY; Meng FL; Rao L; Liu YY; Zhao XL
    Yi Chuan; 2020 Nov; 42(11):1042-1061. PubMed ID: 33229312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells as custom therapeutics for retinal repair: progress and rationale.
    Wright LS; Phillips MJ; Pinilla I; Hei D; Gamm DM
    Exp Eye Res; 2014 Jun; 123():161-72. PubMed ID: 24534198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positioning canine induced pluripotent stem cells (iPSCs) in the reprogramming landscape of naïve or primed state in comparison to mouse and human iPSCs.
    Menon DV; Bhaskar S; Sheshadri P; Joshi CG; Patel D; Kumar A
    Life Sci; 2021 Jan; 264():118701. PubMed ID: 33130086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances.
    Chhabra A
    Stem Cell Rev Rep; 2017 Dec; 13(6):757-773. PubMed ID: 28918520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.
    Yoshihara M; Hayashizaki Y; Murakawa Y
    Stem Cell Rev Rep; 2017 Feb; 13(1):7-16. PubMed ID: 27592701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies to generate induced pluripotent stem cells.
    O'Malley J; Woltjen K; Kaji K
    Curr Opin Biotechnol; 2009 Oct; 20(5):516-21. PubMed ID: 19837580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.
    Zhu D; Kong CSL; Gingold JA; Zhao R; Lee DF
    Adv Exp Med Biol; 2018; 1119():169-183. PubMed ID: 30069853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
    Suh W
    Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.